Four things to know:
1. Mitias Orthopaedics in New Albany, Miss., allegedly billed for a name-brand injectable knee device but actually used a cheaper product from a compound pharmacy.
2. A former pharmaceutical sales rep filed a qui tam lawsuit against the practice, alleging it violated the False Claims Act by receiving reimbursement for the name-brand injectable while using the cheaper product to increase profits.
3. The U.S. government has decided to intervene in the case, and the whistleblower stands to receive a portion of any funds recovered.
4. The lawsuit was filed in the U.S. Court for the Northern District of Mississippi.
More articles on orthopedic surgeons:
9 orthopedic surgeons on the move in January
How total joints’ outpatient migration could affect value-based pay
Rothman orthopedic surgeon appointed medical director of ValueHealth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
